PriceTargets.com logo

RHÖN-KLINIKUM Aktiengesellschaft - RHK Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: €0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
€14.00 As of 12/17/2024 01:00 AM ET
▲ +0.2 (1.45%)

This chart shows the closing price for RHK by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New RHÖN-KLINIKUM Aktiengesellschaft Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RHK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RHK

Analyst Price Target is €0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for RHÖN-KLINIKUM Aktiengesellschaft in the last 3 months. The average price target is €0.00, with a high forecast of €0.00 and a low forecast of €10,000,000.00. The average price target represents a -100.00% upside from the last price of €14.00.

This chart shows the closing price for RHK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in RHÖN-KLINIKUM Aktiengesellschaft. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/21/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/18/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/18/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/8/2020Independent ResearchSet TargetSell€18.00
3/27/2020Independent ResearchSet TargetNeutral€18.00
3/5/2020Independent ResearchSet TargetSell€18.00
3/3/2020Berenberg BankSet TargetNeutral€18.00
3/2/2020Kepler Capital MarketsSet TargetNeutral€18.00
2/26/2020Independent ResearchSet TargetNeutral€17.60
2/24/2020Kepler Capital MarketsSet TargetSell€14.30
2/21/2020Berenberg BankSet TargetNeutral€19.75
(Data available from 12/18/2019 forward)

News Sentiment Rating

0.34 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/22/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/21/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/21/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/20/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/19/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/19/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/18/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/18/2024

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
RHÖN-KLINIKUM Aktiengesellschaft logo
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.
Read More

Today's Range

Now: €14.00
Low: €13.80
High: €14.00

50 Day Range

MA: €12.81
Low: €12.00
High: €13.90

52 Week Range

Now: €14.00
Low: €9.50
High: €14.00

Volume

2,653 shs

Average Volume

43,281 shs

Market Capitalization

$937.16 million

P/E Ratio

19.71

Dividend Yield

1.21%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of RHÖN-KLINIKUM Aktiengesellschaft?

The following sell-side analysts have issued research reports on RHÖN-KLINIKUM Aktiengesellschaft in the last twelve months:
View the latest analyst ratings for RHK.

What is the current price target for RHÖN-KLINIKUM Aktiengesellschaft?

0 Wall Street analysts have set twelve-month price targets for RHÖN-KLINIKUM Aktiengesellschaft in the last year. has the lowest price target set, forecasting a price of €10,000,000.00 for RHÖN-KLINIKUM Aktiengesellschaft in the next year.
View the latest price targets for RHK.

What is the current consensus analyst rating for RHÖN-KLINIKUM Aktiengesellschaft?

RHÖN-KLINIKUM Aktiengesellschaft currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for RHK.

What other companies compete with RHÖN-KLINIKUM Aktiengesellschaft?

Other companies that are similar to RHÖN-KLINIKUM Aktiengesellschaft include Fresenius SE & Co. KGaA, Fresenius Medical Care, Gerresheimer, MorphoSys and Shop Apotheke Europe. Learn More about companies similar to RHÖN-KLINIKUM Aktiengesellschaft.

How do I contact RHÖN-KLINIKUM Aktiengesellschaft's investor relations team?

RHÖN-KLINIKUM Aktiengesellschaft's physical mailing address is Schlossplatz 1, BAD NEUSTADT AN DER SAALE, 97616, Germany. The company's listed phone number is +49-9-771650. The official website for RHÖN-KLINIKUM Aktiengesellschaft is www.rhoen-klinikum-ag.com. Learn More about contacing RHÖN-KLINIKUM Aktiengesellschaft investor relations.